Showing results (1691-1700 of 2,000) with videos related to
Sort By:
Pageof 200
Scientific Reports|June 7, 2017
Solution-Processed Cu2Se Nanocrystal Films with Bulk-Like Thermoelectric PerformanceJason D Forster, Jared J Lynch, Nelson E Coates, et al.Biology of Reproduction|January 27, 2012
ACP5 (Uteroferrin): phylogeny of an ancient and conserved gene expressed in the endometrium of mammalsMaria B Padua, Vincent J Lynch, Natalia V Alvarez, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancerThomas J Lynch, David Fenton, Vera Hirsh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patientsWei Zhou, Rebecca S Heist, Geoffrey Liu, et al.Psychopharmacology|March 5, 2013
Assessment of the abuse liability of ABT-288, a novel histamine H₃ receptor antagonistThomas J Hudzik, Ana Basso, Janel M Boyce-Rustay, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumorsDavid P Ryan, Joseph P Eder, Thomas Puchlaski, et al.Molecular Genetics & Genomic Medicine|August 7, 2015
Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patientKane Greer, Kayla Mizzi, Emily Rice, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancerShirin Khambata-Ford, Christopher T Harbison, Lowell L Hart, et al.Genes and Immunity|June 27, 2001
The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3C Stover, Y Endo, M Takahashi, et al.European Journal of Pharmacology|February 1, 2002
Potent desensitization of human P2X3 receptors by diadenosine polyphosphatesHeath A McDonald, Katharine L Chu, Bruce R Bianchi, et al.Pageof 200